Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), sold 48,800 shares at $21.58 ($1.1M) on 2023-04-24, disclosed to the SEC on 2023-04-26.
Open-market sale of $1.1M KDNY by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.58 | 23,800 | $514K | 48.7% |
| 2 | $21.58 | 23,800 | $514K | 48.7% |
| 3 | $22.26 | 1,200 | $27K | 2.5% |
| Total | $21.60 avg | 48,800 | $1.1M | 100% |
| Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |
| KDNY | BUY | 2022-05-27 | $65K | — | Filing → |